COVID-19 Immunity Task Force (CITF) & CanCOVID Seminar Series: Research Results & Implications​

Moderator:

Speakers:

Joining for the Q&A Session:

Globally, there are limited data on COVID‑19 illness and vaccination during pregnancy to inform recommendations for pregnant people and their care providers and to guide public health policies. For that reason, the COVID‑19 Immunity Task Force (CITF) and CanCOVID are eager to share the latest research from three CITF-supported studies on the impact of SARS-CoV-2 infection and COVID‑19 vaccination on pregnancy and newborns.​

Among the topics to be addressed:​

The results from these studies are communicated regularly to public health officials to help inform decision-making for ongoing COVID‑19 vaccine administration programs in Canada.​

With funding from the Government of Canada

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback